Form 8-K - Current report:
SEC Accession No. 0001104659-25-007098
Filing Date
2025-01-29
Accepted
2025-01-29 11:33:28
Documents
15
Period of Report
2025-01-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm254694d1_8k.htm   iXBRL 8-K 25095
2 EXHIBIT 99.1 tm254694d1_ex99-1.htm EX-99.1 326840
3 EXHIBIT 99.2 tm254694d1_ex99-2.htm EX-99.2 45824
  Complete submission text file 0001104659-25-007098.txt   643139

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ampe-20250121.xsd EX-101.SCH 3024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20250121_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20250121_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT tm254694d1_8k_htm.xml XML 3367
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 25567617
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)